Expanded Access and Compassionate Use in the United States
Expanded Access and Compassionate Use in the United States Expanded Access and Compassionate Use Programs in U.S. Clinical Trials: Regulatory and Practical Insights Introduction Expanded Access (EA) and Compassionate Use programs allow patients with serious or life-threatening diseases to receive investigational drugs outside traditional clinical trials. In the United States, these programs are regulated by…
Read More “Expanded Access and Compassionate Use in the United States” »